The overall objective of the SysMedPD project is to further explore and identify novel drug candidates capable of slowing down the progression of neurodegeneration in the subset of Parkinson’s Disease (PD) patients with overt mitochondrial dysfunction.
This book introduces the emerging field of systems medicine and describes a transition in modern biomedical research. It is the first book of its kind and it contains contributions from leading experts from across Europe.
“Avicenna – A Strategy for in silico Clinical Trials” was a Coordination and Support Action funded by the European Commission. Avicenna was tasked with writing a Roadmap to define the strategy for developing In Silico Clinical Trials.
The main goal of the CombiMS project is to identify a new method for drug discovery based on systems biology and to validate this approach by identifying novel combination therapies for Multiple Sclerosis.